Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 34.34
+2.18 (6.78%)
Apr 14, 2026, 5:29 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 1.75 billion as of April 14, 2026. Its market cap has decreased by -74.33% in one year.
Market Cap
1.75B
Enterprise Value
1.14B
Revenue
992.34M
Ranking
n/a
PE Ratio
26.22
Stock Price
34.34
Market Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 1.75B, an increase of 526.53%. That is a compound annual growth rate of 23.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.64B | -1.05% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.34B |
| Getinge AB | 52.28B |
| Sectra AB | 46.20B |
| Camurus AB | 30.77B |
| Stille AB | 2.00B |
| Cereno Scientific AB | 1.96B |
| Carasent AB | 1.65B |
| EQL Pharma AB | 1.64B |